BPH: Hormone antagonists for two-pronged attack on BPH

Nature Reviews Urology

Volumn 9, Issue 5, 2012, Pages 235-

  Clyne, Melanie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CYCLINE; FINASTERIDE; GROWTH HORMONE RELEASING FACTOR; HORMONE ANTAGONIST; JMR 132; MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

DNA CONTENT; DOWN REGULATION; DRUG EFFICACY; NONHUMAN; NOTE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TREATMENT RESPONSE; UPREGULATION;

EID: 84862159053     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.67     Document Type: Note

References (1)

1. Rick, F. G. et al. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage. J. Urol. 187, 1498-1504 (2012)